Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$0.42 - $0.57 $102,284 - $138,814
-243,535 Reduced 8.43%
2,644,667 $1.27 Million
Q3 2023

Oct 26, 2023

BUY
$0.44 - $0.98 $75,701 - $168,608
172,049 Added 6.33%
2,888,202 $1.68 Million
Q2 2023

Aug 10, 2023

BUY
$0.5 - $0.67 $208,901 - $279,928
417,803 Added 18.18%
2,716,153 $1.44 Million
Q1 2023

May 04, 2023

BUY
$0.66 - $1.13 $253,038 - $433,232
383,392 Added 20.02%
2,298,350 $1.61 Million
Q4 2022

Feb 09, 2023

SELL
$0.85 - $1.54 $1 Million - $1.82 Million
-1,181,660 Reduced 38.16%
1,914,958 $1.76 Million
Q3 2022

Nov 10, 2022

BUY
$1.16 - $1.89 $1.51 Million - $2.45 Million
1,298,584 Added 72.22%
3,096,618 $3.78 Million
Q2 2022

Jul 26, 2022

BUY
$1.23 - $4.14 $224,030 - $754,055
182,139 Added 11.27%
1,798,034 $2.37 Million
Q1 2022

May 10, 2022

BUY
$2.93 - $5.89 $124,299 - $249,871
42,423 Added 2.7%
1,615,895 $6.46 Million
Q4 2021

Feb 08, 2022

SELL
$5.41 - $8.5 $1.23 Million - $1.94 Million
-227,913 Reduced 12.65%
1,573,472 $8.51 Million
Q3 2021

Nov 15, 2021

SELL
$5.95 - $8.88 $118,767 - $177,253
-19,961 Reduced 1.1%
1,801,385 $12.5 Million
Q2 2021

Aug 11, 2021

BUY
$6.86 - $10.23 $4.42 Million - $6.59 Million
643,995 Added 54.7%
1,821,346 $16.5 Million
Q1 2021

May 13, 2021

BUY
$8.96 - $18.92 $5.66 Million - $12 Million
632,079 Added 115.92%
1,177,351 $11 Million
Q4 2020

Feb 10, 2021

BUY
$3.83 - $11.68 $1.56 Million - $4.75 Million
406,585 Added 293.17%
545,272 $4.53 Million
Q3 2020

Nov 12, 2020

BUY
$4.65 - $12.87 $233,695 - $646,807
50,257 Added 56.83%
138,687 $645,000
Q2 2020

Aug 11, 2020

BUY
$5.8 - $17.4 $512,894 - $1.54 Million
88,430 New
88,430 $1.1 Million

Others Institutions Holding ACB

About AURORA CANNABIS INC


  • Ticker ACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 300,436,992
  • Market Cap $1.26B
  • Description
  • Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried ...
More about ACB
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.